Klaus-Peter Radtke

538 total citations
18 papers, 407 citations indexed

About

Klaus-Peter Radtke is a scholar working on Hematology, Genetics and Cancer Research. According to data from OpenAlex, Klaus-Peter Radtke has authored 18 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Klaus-Peter Radtke's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Hemophilia Treatment and Research (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Klaus-Peter Radtke is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Hemophilia Treatment and Research (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Klaus-Peter Radtke collaborates with scholars based in United States, Germany and France. Klaus-Peter Radtke's co-authors include John H. Griffin, José A. Fernández, N. Heimburger, Mary J. Heeb, T. Stief, Andrew J. Gale, J S Greengard, Jessica Riceberg, Michael Cunningham and Jean‐Luc Pellequer and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Biochemistry.

In The Last Decade

Klaus-Peter Radtke

18 papers receiving 395 citations

Peers

Klaus-Peter Radtke
A. Mario Marcondes United States
R. C. Horns United States
P. C. Hoffman United States
E. Klumper Netherlands
Géza Sas United Kingdom
Gretchen A. Radloff United States
Klaus-Peter Radtke
Citations per year, relative to Klaus-Peter Radtke Klaus-Peter Radtke (= 1×) peers Salvatore Nicola Bertuccio

Countries citing papers authored by Klaus-Peter Radtke

Since Specialization
Citations

This map shows the geographic impact of Klaus-Peter Radtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus-Peter Radtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus-Peter Radtke more than expected).

Fields of papers citing papers by Klaus-Peter Radtke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus-Peter Radtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus-Peter Radtke. The network helps show where Klaus-Peter Radtke may publish in the future.

Co-authorship network of co-authors of Klaus-Peter Radtke

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus-Peter Radtke. A scholar is included among the top collaborators of Klaus-Peter Radtke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus-Peter Radtke. Klaus-Peter Radtke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Castelló, Remedios, José María Landete, Francisco España, et al.. (2007). Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer. Thrombosis Research. 120(5). 753–762. 30 indexed citations
2.
Radtke, Klaus-Peter, John H. Griffin, Jessica Riceberg, & Andrew J. Gale. (2006). Disulfide bond‐stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays. Journal of Thrombosis and Haemostasis. 5(1). 102–108. 39 indexed citations
3.
Gale, Andrew J., Klaus-Peter Radtke, Michael Cunningham, et al.. (2006). Intrinsic stability and functional properties of disulfide bond‐stabilized coagulation factor VIIIa variants. Journal of Thrombosis and Haemostasis. 4(6). 1315–1322. 37 indexed citations
4.
Murphy, John E., Clark Q. Pan, Baisong Mei, et al.. (2006). Towards a New Therapy for Hemophilia A: Evaluation of Multiple Approaches To Prolong the In Vivo Efficacy of Recombinant Factor VIII.. Blood. 108(11). 1606–1606. 3 indexed citations
5.
Heeb, Mary J., et al.. (2006). Plasma contains protein S monomers and multimers with similar direct anticoagulant activity. Journal of Thrombosis and Haemostasis. 4(10). 2215–2222. 19 indexed citations
6.
Sarafanov, Andrey G., Makogonenko Em, Igor Pechik, et al.. (2006). Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein,. Biochemistry. 45(6). 1829–1840. 30 indexed citations
7.
Autin, Ludovic, Maria A. Miteva, Wen‐Hwa Lee, et al.. (2005). Molecular models of the procoagulant Factor VIIIa–Factor IXa complex. Journal of Thrombosis and Haemostasis. 3(9). 2044–2056. 23 indexed citations
8.
Radtke, Klaus-Peter, Dean Chamberlain, John H. Griffin, & Andrew J. Gale. (2004). Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants.. Blood. 104(11). 2976–2976. 1 indexed citations
9.
Fernández, José A., Mary J. Heeb, Klaus-Peter Radtke, & John H. Griffin. (1997). Potent Blood Coagulant Activity of Human Semen Due to Prostasome-Bound Tissue Factor1. Biology of Reproduction. 56(3). 757–763. 53 indexed citations
10.
Greengard, J S, José A. Fernández, Klaus-Peter Radtke, & John H. Griffin. (1995). Identification of candidate residues for interaction of protein S with C4b binding protein and activated protein C. Biochemical Journal. 305(2). 397–403. 26 indexed citations
11.
Radtke, Klaus-Peter, José A. Fernández, J S Greengard, et al.. (1994). Protein C inhibitor is expressed in tubular cells of human kidney.. Journal of Clinical Investigation. 94(5). 2117–2124. 39 indexed citations
12.
Henschen, Agnes, H. Bohn, N. Heimburger, et al.. (1991). Identity between the placental protein PP10 and the specific plasminogen activator inhibitor of placental type PAI-2. Biochimica et Biophysica Acta (BBA) - General Subjects. 1074(1). 74–78. 2 indexed citations
13.
Hemmer, Christoph Josef, et al.. (1990). P. falciparum malaria with procoagulant changes and increased TNF-α serum level.. Journal of Molecular Medicine. 68(5). 281–285. 1 indexed citations
14.
Kern, P., et al.. (1990). Malaria tropica mit Gerinnungsaktivierung und Nachweis von Tumornekrosefaktor (TNF-α) im Serum. Journal of Molecular Medicine. 68(5). 281–285. 2 indexed citations
15.
Radtke, Klaus-Peter, et al.. (1990). Isolation of Plasminogen Activator Inhibitor-2 (PAI-2) from Human Placenta. Evidence for Vltronectin/PAI-2 Complexes in Human Placenta Extract. Biological Chemistry Hoppe-Seyler. 371(2). 1119–1128. 13 indexed citations
16.
Radtke, Klaus-Peter, T. Stief, & N. Heimburger. (1988). A New and Simple Isolation Procedure for Human Protein C Inhibitor. Evidence for a Second Inhibitor for Activated Protein C Present in Human Plasma. Biological Chemistry Hoppe-Seyler. 369(2). 965–974. 6 indexed citations
17.
Stief, T., Klaus-Peter Radtke, & N. Heimburger. (1987). Inhibition of Urokinase by Protein C-Inhibitor (PCI). Evidence for Identity of PCI and Plasminogen Activator Inhibitor 3. Biological Chemistry Hoppe-Seyler. 368(2). 1427–1434. 48 indexed citations
18.
Seitz, Rainer, et al.. (1987). Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections. European Journal Of Haematology. 38(3). 231–240. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026